146 related articles for article (PubMed ID: 27051773)
21. Botulinum toxin-A: A novel treatment for livedoid vasculopathy.
Crotty AM; Eubanks BN; Katana VG; Wright KT
JAAD Case Rep; 2022 Nov; 29():27-29. PubMed ID: 36186404
[No Abstract] [Full Text] [Related]
22. Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy.
Chen W; Fan L; Wang Y; Deng X
J Pain Res; 2017; 10():621-624. PubMed ID: 28360530
[TBL] [Abstract][Full Text] [Related]
23. Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a retrospective study.
Zhao C; Yu M; Cheng X; Li S; Feng S
Clin Exp Dermatol; 2024 Jan; ():. PubMed ID: 38287670
[TBL] [Abstract][Full Text] [Related]
24. Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.
Weishaupt C; Strölin A; Kahle B; Kreuter A; Schneider SW; Gerss J; Eveslage M; Drabik A; Goerge T
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1784-1791. PubMed ID: 31009111
[TBL] [Abstract][Full Text] [Related]
25. Rivaroxaban for treatment of livedoid vasculopathy: A systematic review.
Gao Y; Jin H
Dermatol Ther; 2021 Sep; 34(5):e15051. PubMed ID: 34197012
[TBL] [Abstract][Full Text] [Related]
26. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
Reagin H; Marks E; Weis S; Susa J
Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
[TBL] [Abstract][Full Text] [Related]
27. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
28. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
Hairston BR; Davis MD; Pittelkow MR; Ahmed I
Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
[TBL] [Abstract][Full Text] [Related]
29. Livedoid vasculopathy: an intringuing cutaneous disease.
Criado PR; Rivitti EA; Sotto MN; Valente NY; Aoki V; Carvalho JF; Vasconcellos C
An Bras Dermatol; 2011; 86(5):961-77. PubMed ID: 22147037
[TBL] [Abstract][Full Text] [Related]
30. Livedoid vasculopathy - a thrombotic disease.
Kerk N; Goerge T
Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
[TBL] [Abstract][Full Text] [Related]
31. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
Meiss F; Marsch WC; Fischer M
Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
[TBL] [Abstract][Full Text] [Related]
32. Livedoid vasculopathy: A review of pathogenesis and principles of management.
Vasudevan B; Neema S; Verma R
Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
[TBL] [Abstract][Full Text] [Related]
33. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
[TBL] [Abstract][Full Text] [Related]
34. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
35. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
36. Rivaroxaban in the treatment of livedoid vasculopathy: A long-term retrospective study.
Deng S; Liu Y; Huang J; Shi W
JAAD Int; 2024 Mar; 14():36-38. PubMed ID: 38415054
[No Abstract] [Full Text] [Related]
37. Mononeuropathy multiplex in association with livedoid vasculitis.
Toth C; Trotter M; Clark A; Zochodne D
Muscle Nerve; 2003 Nov; 28(5):634-9. PubMed ID: 14571469
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
[TBL] [Abstract][Full Text] [Related]
39. Homeopathic treatment in resistant livedoid vasculopathy: case report.
Waisse-Priven S; Jurj G; Lima Thomaz LC; Tierno SA; Filho WL; Sos AB
Homeopathy; 2009 Jul; 98(3):165-8. PubMed ID: 19647211
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis.
Renner R; Dissemond J; Goerge T; Hoff N; Kröger K; Erfurt-Berge C
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1884-1889. PubMed ID: 28252815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
